title: Unpacking and Understanding the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Apolipoprotein B Metabolism.
authors.affiliation: From Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom. chris.j.packard@gmail.com.
authors.forename: Chris J
authors.initials: CJ
authors.lastname: Packard
mesh_terms: D001055:Apolipoproteins B; D008078:Cholesterol, LDL; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D011973:Receptors, LDL; D013381:Subtilisins
chemical_list: D001055:Apolipoproteins B; D008078:Cholesterol, LDL; D011973:Receptors, LDL; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D013381:Subtilisins
keywords: Editorials; PCSK9 protein, human; lipoproteins